Shamim MZ, Mishra AK, Kausar T, Mahanta S, Sarma B, Kumar V, et al
GHK-Cu peptide therapy is not intended to replace healthy skincare habits or medical treatments
10.7717/peerj.16875 31 Di RaimoR.MizzoniD.AloiA.PietrangeloG.DoloV.PoppaG.et al (2024)
Also known as: Akos024437838 Molecular Formula C 11 H 21 NO 9 Molecular Weight 311.29 g/mol InChI Key RZALONVQKUWRRY-XOJLQXRJSA-N 1 2D Structure 2 Identification 2.1 Computed Descriptors 2.1.1 IUPAC Name (2R,3R)-2,3-dihydroxybutanedioic acid;(3R)-3-hydroxy-4-(trimethylazaniumyl)butanoate 2.1.2 InChI InChI=1S/C7H15NO3.C4H6O6/c1-8(2,3)5-6(9)4-7(10)11;5-1(3(7)8)2(6)4(9)10/h6,9H,4-5H2,1-3H3;1-2,5-6H,(H,7,8)(H,9,10)/t6-;1-,2-/m11/s1 2.1.3 InChI Key RZALONVQKUWRRY-XOJLQXRJSA-N 2.1.4 Canonical SMILES C[N+](C)(C)CC(CC(=O)[O-])O.C(C(C(=O)O)O)(C(=O)O)O 2.1.5 Isomeric SMILES C[N+](C)(C)C[C@@H](CC(=O)[O-])O.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O 2.2 Synonyms 2.2.1 Depositor-Supplied Synonyms 2.3 Create Date 3 Chemical and Physical Properties
Meyer D
J Cell Biochem 104:13561363 Kawanishi N, Sugimoto T, Shibata J, Nakamura K, Masutani K, Ikuta M, Hirai H (2006) Structure-based drug design of a highly potent CDK1, 2, 4, 6 inhibitor with novel macrocyclic quinoxalin-2-one structure
